Image

Global Analgesics Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • May 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Analgesics Market, By Pain Type (Acute, Chronic), Drug Class (Nonsteroidal Anti-inflammatory Drug (NSAIDs), Opioids, Salicylates, Others), Type (Prescription drugs, Over-the-counter (OTC) drugs), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029

Analgesics Market

Market Analysis and Size                              

According to the National Institute of Health, 20% of adults in the United States suffer from chronic pain, with 8% having high-impact chronic pain. According to a National Center for Health Statistics research covering the last decade, one out of every four Americans has experienced pain that lasts more than a day. Pain management has become a key issue for healthcare practitioners all over the world as the incidence of arthritis and acute chronic diseases rises. The demand for analgesics and painkillers is increasing as a result of these advancements.

Data Bridge Market Research analyses that the analgesics market was valued at USD 49.02 billion in 2021 and is expected to reach USD 70.73 billion by 2029, registering a CAGR of 4.69% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Pain Type (Acute, Chronic), Drug Class (Nonsteroidal Anti-inflammatory Drug (NSAIDs), Opioids, Salicylates, Others), Type (Prescription drugs, Over-the-counter (OTC) drugs), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Hikma Pharmaceuticals PLC (U.K.), Dr. Reddy’s Laboratories Ltd. (India), Lupin (India), Fresenius Kabi AG (Germany), Aurobindo Pharma (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Apotex Inc. (Canada), Eli Lilly and Company (U.S.)

Market Opportunities

 

  • Increasing number of strategic collaborations
  • Rising number of research and development activities

Market Definition

Analgesics, often known as painkillers or pain relievers, are medications that serve to reduce pain without altering awareness, sensory perception, or nerve impulse conduction. Paracetamol (acetaminophen), nonsteroidal anti-inflammatory drugs (NSAIDs) including salicylates, and opioids such as morphine and oxycodone are among these pharmaceuticals. Pain from physiological injuries, operations, phantom aches, inflammation, neuropathic diseases, and cancer treatments are all treated with analgesics.

Analgesics Market Dynamics

Drivers

  • Increasing prevalence of chronic diseases

The increasing number of patients suffering from chronic diseases will fuel industry growth. The rise in cardiovascular disorders is propelling the industry forward. Analgesic medications are used to treat and relieve chronic or severe pain caused by a variety of medical problems. According to a briefing provided in 2019 by the US Centers for Disease Control and Prevention's National Center for Health Statistics, over 20% of Americans suffer from chronic pain. In addition, the prevalence of diseases such as cancer has increased, increasing the number of people who suffer from chronic pain.

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of analgesics market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, surging geriatric population and rise in the number of government initiatives to spread awareness will result in the expansion of analgesics market. Along with this, sedentary lifestyle of people and increasing level of disposable income will enhance the growth rate of the market.

Opportunities

  • Increasing number of strategic collaborations

Companies in the analgesics industry are increasingly turning to acquisition as a growth strategy. To acquire a competitive advantage and strengthen their market position, leading analgesic medicine producers are purchasing smaller enterprises. These purchases aid organizations in expanding regionally and gaining specialized expertise in new product research and development. WCG, for instance, purchased Analgesic Solutions, LLC in 2019. WCG seeks to grow and position itself as a market leader in the analgesic sector by leveraging Analgesic Solutions, LLC's outstanding R&D expertise. This will further create new market opportunities during the forecast period of 2022-2029.

Moreover, the market's growth is fueled by an increase in the number of research and development activities and emerging new markets. These factors will provide beneficial opportunities for the analgesics market growth.

Restraints/Challenges

  • Rising use of biologics

The rising use of biologics for the treatment of inflammatory and neuropathic pain is limiting the expansion of the analgesics market. Biologics are medications made from living organisms that contain a variety of ingredients taken from humans, animals, and microorganisms. Protein, modified human hormones, or cells that create compounds that suppress or stimulate components of the immune system may be found in these medications. Biologics have a higher efficacy than analgesics, which only provide effective pain relief in 50% of patients, and are therefore commonly employed nowadays.

On the other hand, high cost of drug development and distribution will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and dearth of skilled professionals will challenge the analgesics market. Additionally, lack of awareness among people and strict government regulations will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This analgesics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the analgesics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Analgesics market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Analgesics Market

The global analgesics market was impacted by the COVID-19 outbreak. The pandemic had a favourable impact on the market, since increased focus on personal health encouraged purchases of these medications. The demand for over-the-counter cold and cough medicines was already high, and nutritional supplements were likely to expand at a faster rate due to COVID-19. Furthermore, the European Medicines Agency has advised using non-steroidal anti-inflammatories (NSAIDs) such as ibuprofen and paracetamol to treat moderate COVID-19 symptoms at the lowest dose possible. Additionally, because geriatric population are more vulnerable to infection due to weakening immune systems and the lack of a vaccine or therapy, the number of older persons infected with COVID-19 was considerable. Hence, all these factors increased the demand of analgesics market during the pandemic period.

Recent Acquisition

  • In July 2021, Heron Therapeutics Inc. had announced the launch of ZYNRELEF. It's an extended-release solution for soft tissue or periarticular installation in adults to provide postsurgical analgesia for up to 72 hours following a bunionectomy, open inguinal herniorrhaphy, or total knee arthroplasty.

Global Analgesics Market Scope

The analgesics market is segmented on the basis of pain type, drug class, type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Pain Type

  • Acute
  • Chronic

Drug Class

  • Nonsteroidal Anti-inflammatory Drug (NSAIDs)
  • Opioids
  • Salicylates
  • Others

Type

  • Prescription drugs
  • Over-the-counter (OTC) drugs

Route of Administration

  • Oral
  • Parenteral
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Analgesics Market Regional Analysis/Insights

The analgesics market is analysed and market size insights and trends are provided by country, pain type, drug class, type, route of administration, end-users and distribution channel as referenced above.

The countries covered in the analgesics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the analgesics market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing prevalence of chronic and acute pain and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, growing presence of major key players and rise in adoption of newer technologies will further propel the market’s growth rate in this region.

Asia-Pacific is expected to be the fastest growing region during the forecast period of 2022-2029 due to surging level of disposable income in this region. Also, development of healthcare infrastructure and rising number of generic drug manufacturer will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Analgesics Market Share Analysis

The analgesics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to analgesics market.

Some of the major players operating in the analgesics market are:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Ireland)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • GlaxoSmithKline plc (U.K.)
  • Novartis AG (Switzerland)
  • Merck & Co., Inc. (U.S.)
  • AstraZeneca (U.K.)
  • Johnson & Johnson Private Limited (U.S.)
  • Hikma Pharmaceuticals PLC (U.K.)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Fresenius Kabi AG (Germany)
  • Aurobindo Pharma (India)
  • Bausch Health Companies Inc. (Canada)
  • Amneal Pharmaceuticals LLC. (U.S.)
  • Apotex Inc. (Canada)
  • Eli Lilly and Company (U.S.)
  • Cipla Inc. (U.S.)
  • Lupin (India)

Research Methodology: Global Analgesics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The market value for the analgesics market is expected USD 70.73 billion by 2029.
The analgesics market is to grow at a CAGR of 4.69% during the forecast period of 2022 to 2029.
The major players operating in the Analgesics Market are F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Hikma Pharmaceuticals PLC (U.K.), Dr. Reddy’s Laboratories Ltd. (India), Lupin (India), Fresenius Kabi AG (Germany), Aurobindo Pharma (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Apotex Inc. (Canada), Eli Lilly and Company (U.S.).
The major countries covered in the Analgesics Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.